ACCORSI BUTTINI, EUGENIA
 Distribuzione geografica
Continente #
NA - Nord America 190
EU - Europa 144
AS - Asia 42
SA - Sud America 2
OC - Oceania 1
Totale 379
Nazione #
US - Stati Uniti d'America 188
IT - Italia 65
FI - Finlandia 28
DE - Germania 18
HK - Hong Kong 18
CN - Cina 13
GB - Regno Unito 8
IE - Irlanda 8
IN - India 5
SE - Svezia 5
UA - Ucraina 5
FR - Francia 4
SG - Singapore 3
BR - Brasile 2
CA - Canada 2
GR - Grecia 2
AU - Australia 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 379
Città #
Chandler 32
Helsinki 27
New York 19
Hong Kong 18
Brescia 15
Fairfield 15
Ashburn 14
Seattle 14
Shanghai 9
Barlassina 8
Dublin 8
Woodbridge 8
Milan 7
Wilmington 7
Cambridge 6
Jacksonville 6
Houston 5
Pune 5
Pescara 4
Princeton 4
Rome 4
Athens 2
Casanova Lonati 2
Chicago 2
Chiswick 2
Des Moines 2
Mazzano 2
São Paulo 2
Turin 2
Beijing 1
Bergamo 1
Boardman 1
Brooklyn 1
Cachan 1
Florence 1
Hounslow 1
Jinan 1
Kocaeli 1
La Spezia 1
Lappeenranta 1
Lequio Tanaro 1
London 1
Los Angeles 1
Margherita di Savoia 1
Melbourne 1
Ningbo 1
North York 1
Ramallah 1
Redwood City 1
Riyadh 1
Roverbella 1
Singapore 1
Strasbourg 1
Tianjin 1
Totale 276
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 112
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 40
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 38
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 36
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 27
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 25
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 22
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 17
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 17
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 15
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 14
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 11
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 9
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 7
Totale 390
Categoria #
all - tutte 3.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 1 10 9 6 6 7 4 1 5
2020/202132 1 2 2 1 1 7 0 4 2 7 1 4
2021/202223 0 0 0 6 0 1 0 1 0 4 7 4
2022/2023132 7 2 3 18 12 23 0 13 17 7 16 14
2023/2024154 6 7 18 14 24 40 4 14 22 4 1 0
Totale 390